Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding Drug Sensitivity and Tackling Resistance in Cancer
Jeffrey W. Tyner, Franziska Haderk, Anbarasu Kumaraswamy, et al.
Cancer Research (2022) Vol. 82, Iss. 8, pp. 1448-1460
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

TGF-β, EMT, and resistance to anti-cancer treatment
Xuecong Wang, Pieter J.A. Eichhorn, Jean Paul Thiery
Seminars in Cancer Biology (2023) Vol. 97, pp. 1-11
Open Access | Times Cited: 53
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 33
Plant-derived nanovesicles: Further exploration of biomedical function and application potential
Aixue Li, Dan Li, Yongwei Gu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3300-3320
Open Access | Times Cited: 39
Tackling Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Cancer
Juan Bautista Blaquier, Sandra Ortiz-Cuarán, Biagio Ricciuti, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 18, pp. 3579-3591
Closed Access | Times Cited: 37
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse
Mengnuo Chen, Sara Mainardi, Cor Lieftink, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101471-101471
Open Access | Times Cited: 12
Inhalable Nano Formulation of Cabazitaxel: A Comparative Study with Intravenous Route
Elif Kağa, Sadık Kağa, Korhan Altunbas, et al.
Macromolecular Bioscience (2025)
Open Access | Times Cited: 1
Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine
Josephine A. Taverna, Chia‐Nung Hung, Madison Williams, et al.
Lung Cancer (2024) Vol. 190, pp. 107533-107533
Open Access | Times Cited: 8
A Review of the Efficacy of Nanomaterial-Based Natural Photosensitizers to Overcome Multidrug Resistance in Cancer
Jagadeesh Rajaram, Lokesh Kumar Mende, Yaswanth Kuthati
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1120-1120
Open Access | Times Cited: 7
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Astha Lamichhane, Hossein Tavana
Cellular and Molecular Bioengineering (2024) Vol. 17, Iss. 2, pp. 107-119
Open Access | Times Cited: 5
Antibody–Drug Conjugates—Evolution and Perspectives
Adriana Aurelia Chiș, Carmen Maximiliana Dobrea, Anca Maria Arseniu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 5
Targeting protein synthesis pathways in MYC-amplified medulloblastoma
Devendra Kumar, Ranjana Kanchan, Nagendra K. Chaturvedi
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies
Suman Giri, Gopal Lamichhane, Jitendra Pandey, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2923-2923
Open Access
Peritoneal Metastasis Mimicking Chemotherapy-Induced Complications in Lung Adenocarcinoma: A Diagnostic Challenge of a Case Report
Ryuichi Ohta, Kaoru Tanaka, Masayuki Miyata, et al.
Cureus (2025)
Open Access
MARCKS as a Target for Pathological Tunneling Nanotubes in Glioblastoma
Christopher D. Willey, Lauren Nassour, M. Shehata Ahmed, et al.
Research Square (Research Square) (2025)
Closed Access
Persister cell plasticity in tumour drug resistance
Paul C. McDonald, Shoukat Dedhar
Seminars in Cell and Developmental Biology (2023) Vol. 156, pp. 1-10
Closed Access | Times Cited: 10
BMS-794833 reduces anlotinib resistance in osteosarcoma by targeting the VEGFR/Ras/CDK2 pathway
Qingtao Meng, Han Jian, Peng Wang, et al.
Journal of bone oncology (2024) Vol. 45, pp. 100594-100594
Open Access | Times Cited: 3
Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 8, pp. 1095-1108
Closed Access | Times Cited: 3
Pd(II) and Pt(II) Trinuclear Chelates with Spermidine: Selective Anticancer Activity towards TNBC-Sensitive and -Resistant to Cisplatin
Martin Vojtek, Clara B. Martins, Raquel Ramos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1205-1205
Open Access | Times Cited: 6
Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity
Yuan-Xiang Shi, Jian-Hua Yan, Wen Liu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
The updates on metastatic mechanism and treatment of colorectal cancer
Yunfei Ni, You Liang, Mingzhou Li, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154837-154837
Closed Access | Times Cited: 6
YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer
Miao Huang, Heyang Wang, Cole Mackey, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12491-12491
Open Access | Times Cited: 4
Evidence of direct interaction between cisplatin and the caspase‐cleaved prostate apoptosis response‐4 tumor suppressor
Krishna K. Raut, Samjhana Pandey, Gyanendra Kharel, et al.
Protein Science (2023) Vol. 33, Iss. 3
Open Access | Times Cited: 4
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Learning chemical sensitivity reveals mechanisms of cellular response
William Connell, Kristle Garcia, Hani Goodarzi, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine/Tipiracil) in digestive cancers by overexpressing Thymidine Phosphorylase
Marie Malier, Marie‐Hélène Laverrière, Maxime Henry, et al.
Cancer Letters (2024) Vol. 606, pp. 217307-217307
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top